Alexis Borisy - 09 May 2022 Form 4/A - Amendment Insider Report for OPKO HEALTH, INC. (OPK)

Role
Director
Signature
Steven D. Rubin, Attorney-in-Fact
Issuer symbol
OPK
Transactions as of
09 May 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
13 May 2022, 18:19:22 UTC
Date Of Original Report
11 May 2022
Previous filing
20 Dec 2021
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPK Common Stock Award $0 +312,612 $0.000000 312,612 09 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPK Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 09 May 2022 Common Stock 50,000 $2.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 9, 2022, the Issuer awarded the Reporting Person restricted stock in the amount indicated in connection with the merger between the Issuer and ModeX Therapeutics, Inc. ("ModeX"), pursuant to which ModeX became a subsidiary of the Issuer.

Remarks:

This form is being amended to correct the footnote to Column 4 in Table I.